2019 Will Be a Year of Regulation for Big Tech
Tech industry regulation is coming in 2019 according to analyst Doug Clinton of Loup Ventures. The European Union's GDPR rules are a likely model for new U.S. regulation.
Archive
Month: January 2019
All Month: January 2019 Articles
Newest first · Page 40
Stealth Bio Gears Up for IPO
Clinical-stage biotechnology company Stealth Biotherapeutics has filed with the SEC regarding its initial public offering.
5 Most-Returned Holiday Gifts
Now that holiday gift-giving is behind us, holiday gift return season can hit its stride. Here are some data on just how many returns retailers can expect and what the most often-returned gifts are.
How Paratek Could Rise 170% Due to Strong Infectious Disease Treatment Expectations
Could this small clinical-stage emerging pharmaceuticals outfit have upside of almost 200%? That's what one firm has said on the first trading day of 2019.
December Purchasing Managers Index Points to Slower Growth
For those who were hoping for 4% growth in gross domestic product to continue late in 2018 and into 2019, the first economic release of 2019 might continue to temper expectations.
Why Cara Therapeutics Is One of Wednesday’s Big Winners
Cara Therapeutics shares jumped on Wednesday after the firm announced a key update in its late-stage chronic kidney disease trial.
Is Tesla’s Delivery Shortfall the Real Problem?
Tesla reported fourth-quarter delivery and production numbers Wednesday morning. Although close to estimates, investors have no patience for close. The company also announced a price cut on all its cars.
Meet Activision Blizzard’s ‘New’ CFO
Activision Blizzard shares dipped on Wednesday after the firm announced that it would be making a change in its top-level leadership.
CoreLogic November Home Price Index Continues Slower Growth
The CoreLogic home price index rose 5.1% year over year in November, once again posting a smaller annual gain than in the previous month. Higher interest rates and falling prices are combining to tamp…
Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix and Sirius XM.
TCR2 Therapeutics Files for IPO
Immunotherapy company TCR2 Therapeutics has filed with the SEC regarding its initial public offering.
Mattis Firing Delays Delivery of Boeing Tanker to US Air Force
The firing of Defense Secretary Jim Mattis has delayed acceptance of Boeing's new KC-46 tanker beyond December 2018. Deliveries were originally set to begin in August 2017.
10 Largest Marijuana Companies
Initial public offerings and significant investment by established firms raised the valuations of several companies in the marijuana-related sector. Here are the 10 largest firms at the end of 2018.
Cowan: Apple supply chain lumpy but on track
From a note to clients that landed on my desktop Wednesday.
China’s Manufacturing Economy Runs Into Problems: Is Trade War to Blame?
China's manufacturing economy contracted in December, a rare occurrence in the largest manufacturing nation in the world.